Pfizer Inc. (PFE)

Source: Benzinga

Pfizer Inc (NYSE: PFE ) and BioNTech SE (NASDAQ: BNTX ) have started clinical trials of their jointly-developed COVID-19 vaccine with children, the companies said in a statement Thursday. What Happened: The vaccine trials involve healthy participants aged 6 months to 11-years and the first participants have already received the shots. The multinational pharmaceutical giant reportedly plans to enroll 144 children in the first phase of the trial. In the first phase of the trial, Pfizer will identify the dosing levels for three age groups — between 6 … Full story available on Benzinga.com

Read Full Article

Source: Investing.com

https://www.investing.com/news/coronavirus/pfizer-executive-says-eu-export-restrictions-on-covid19-vaccines-would-be-a-loselose-situation-2457532

Read Full Article

Source: Business Insider

Summary List Placement Millions of newly inoculated Americans are walking home with paper vaccine cards containing crucial information about their COVID-19 vaccine. The CDC-issued paper COVID-19 vaccine cards serve as reminders for when to get a second dose of the Moderna or Pfizer vaccine. The CDC is not collecting information on who received COVID-19 vaccines, meaning the paper card also works as proof that you’ve gotten your shot. What happens if you lose the small paper card? You can still get a second dose, but the CDC recommends taking a photo of the card upon receiving it. (But remember not to share photos of your vaccine card on social media.) Here’s everything to know about your COVID-19 vaccine card: What are COVID-19 vaccine cards? The Trump administration designed the cards as ways to remind vaccine recipients when to get a second dose. Recipients or their vaccine providers write when they got the first dose and what shot they received on the cards. The Moderna vaccine requires two doses taken four weeks apart, and the Pfizer vaccine requires two shots three weeks apart.

Read Full Article

Source: Benzinga

AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China , March 25, 2021 /CNW/ — Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine , a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. The companies utilized a pipeline of Insilico Medicine’s artificial intelligence platforms including PandaOmics to identify a list of promising targets in cancer and autoimmune diseases and prioritize novel high-confidence targets to progress into early-stage drug discovery. ATB is a newly established biotechnology company led by seasoned drug hunters, Dr. Yuan-Hua Ding (CEO) and Dr. Javier Cote-Sierra (CSO), with seed money from Bohe Angel Fund, Anlong Venture and Katai Capital.

Read Full Article

Source: Economic Times India

Why is AstraZeneca Plc making so many unforced errors in its attempt to distribute billions of doses of Covid vaccines to the world at minimal cost? Once the pandemic is under control, the Anglo-Swedish drugmaker should examine whether there’s a problem with the way it makes decisions.AstraZeneca agreed in April to help develop, manufacture and distribute Oxford University’s jab against Covid-19. It had no business in vaccines: The aim was to bring its resources to the pandemic fight on a non-profit basis. These assets include a global network and established capabilities in running large clinical trials. The outcome is millions of jabs administered within a year. However, the lack of vaccine expertise, an overconfidence in what the firm could achieve and a naivety about the politics of the task cannot be brushed aside.One issue has been communication of scientific results. November data from trials in the U.K. and Brazil generated confusion over efficacy. This week, there were doubts over a subsequent trial in the U.S. and South America that was supposed to clear up the question.

Read Full Article

Source: Forexlive

A study shared by the New England Journal of Medicine This is based on data from the University of Texas Southwestern Medical Center (UTSW), which started its vaccination program on 15 December last year to offer frontline employees either the Pfizer or Moderna vaccines based on emergency-use authorisation. By Justin Low

Read Full Article

Source: Business Insider

Summary List Placement We know the COVID-19 vaccines work extremely well, but we never thought they would be perfect. Even with efficacy rates as high as 95% in Pfizer trials, there’s still a small chance of getting infected with the coronavirus after you’re fully vaccinated. Now that the vaccine rollout is well underway in the US, we’re starting to see a few “breakthrough” cases pop up. Two letters to the editor published in the New England Journal of Medicine this week summed up these rare post-vaccine infections at three different hospital systems. Just four out of 8,121 fully vaccinated employees at the University of Texas Southwestern Medical Center in Dallas tested positive for COVID-19 between December 15, 2020, and January 28, 2021. At UC San Diego Health and the David Geffen School of Medicine at the University of California, Los Angeles, only seven out of 14,990 healthcare workers tested positive two or more weeks after receiving a second dose of either the Pfizer-BioNTech or Moderna vaccines.

Read Full Article

Source: Benzinga

This is an excerpt from the March 23, 2021 edition of Medically Necessary, a health care supply chain newsletter . Subscribe here. Good afternoon. Medically Necessary is a newsletter by Matt Blois about the health care supply chain — how we get drugs, devices and medical supplies to health care providers and patients. Fake vaccines, protective equipment threaten the supply chain An Immigration and Customs Enforcement agent inspects international cargo with personal protective equipment in the Los Angeles area. (Photo: ICE) Threats: Criminals are trying to sell fake COVID-19 vaccines to desperate governments and citizens, threatening trust in the real health care supply chain. Reports of counterfeit vaccines follow months of problems with counterfeit personal protective equipment. Fake shots: Early this month, the international law enforcement agency INTERPOL reported seizing thousands of fake COVID-19 vaccines . With support from INTERPOL, South African authorities recovered about 400 ampules in a warehouse near Johannesburg.

Read Full Article

Source: The Guardian

Latest updates: Boris Johnson made comments in Zoom call with Tory MPs that the UK’s successful vaccine programme was thanks to ‘greed’ and ‘capitalism’ ‘Greed’ and ‘capitalism’ behind vaccine success, Johnson tells MPs Coronavirus – latest updates See all our coronavirus coverage 9.21am GMT Good morning. When Boris Johnson makes false claims, as he does regularly in parliament, he is notoriously unwilling to retract them. But last night, when he made an infelicitous comment on a private Zoom call with Tory backbenchers, he withdrew it almost immediately – even though at the time he was being much more honest than he often is. This is what he said: The reason we have the vaccine success is because of capitalism, because of greed, my friends. Related: Covid: ‘greed’ and ‘capitalism’ behind vaccine success, Johnson tells MPs The prime minister always acknowledges the strong success we’ve had in terms of the vaccine, not just the rollout, which is incredible, but also our ability as a country to develop the vaccine, the role that pharmaceutical companies and science and technology has played in that.

Read Full Article

Source: City AM

Pfizer has begun early-stage human trials of a pill to treat the first signs of Covid infection, the company announced The post Pfizer begins trials of pill to treat Covid infection appeared first on CityAM .

Read Full Article